TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| CEM gets microwave patent CEM Corp., a Matthews-based maker of laboratory instruments, has received a fourth U.S. patent for microwave-assisted peptide synthesis. feeds.bizjournals.com |
BioSante Pharma's LibiGel: Big Upside Potential Mike Havrilla submits:BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception, and male testosterone deficiency (hypogonadism). The company’s wholly-owned lead product is LibiGel (transdermal testosterone gel), which is in Phase 3 clinical development by BioSante under dual Special Protocol Assessments (SPAs) for the treatment of female sexual dysfunction (FSD).On 9/22/09, BioSante and Cell Genesys (NASDAQ: CEGE) announced that they have determined the final exchange ratio will be 0.1828 in connection with the previously announced merger between the companies. If the merger is completed, CEGE shareholders will receive 0.1828 of a share of BPAX common stock for each share of CEGE common stock they hold immediately prior to the effective time of the merger. Each company is scheduled to hold a special meeting of stockholders on 9/30/09 at which time shareholders will be asked to approve the merger, and both companies expect to close the proposed merger promptly after such stockholder approvals have been obtained.Complete Story » seekingalpha.com |
Court Rejects Drug-Patent Challenge The Supreme Court Monday rejected a generic-drug maker's appeal challenging a patent for a blood-thinning drug developed by Sanofi-Aventis. online.barrons.com |
SIGA Shares Could Double on Pending Government News BioMedReports has learned that shares of this bio-defense company engaged in the discovery, development and commercialization of products for use in defense against biological warfare agents, such as smallpox and arenaviruses is expecting big news and government orders.Our Subscribers were alerted Monday that a series of big government orders are anticipated to be announced "any day now," after sources confirmed to us that the official news and first purchase order could come within days.SIGA Technologies, Inc. (NASDAQ:SIGA) has been trading up since late Thursday, when funds and others who were holding short positions started to cover in anticipation of this news.Complete Story » seekingalpha.com |
Neostem: Ready to Take Off? M.E. Garza submits: This morning's news release by NeoStem (NBS) is a peek into the metamorphasis we learned would be taking place at the company last week.During our exclusive interview with Robin L. Smith M.D., Chairman of the Board and Chief Executive Officer of NeoStem Inc., last week, she shared a few promising glimpses about the company's future. But some of the revelations we found after digging through some of the company's recent filings really start to put things into focus more clearly after today's announcement.Complete Story » seekingalpha.com |